In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
The ELZA Institute’s surgeons and researchers were in Frankfurt this month to present our latest research and results at Winter ESCRS 2024.
Expertscape continuously monitor the research output of all peer-reviewed publication on PubMed and rank the top researchers across all of Medicine. Currently, ELZA has #1, #2 and #5 for corneal cross-linking.
Last week, Prof Hafezi gave a keynote lecture at the International Keratoconus & Corneal Crosslinking Summit 2024, held in Shanghai, China, on the topic of “The Future of Keratoconus Care Without Corneal Transplantation”
The Ophthalmologist’s “CXL: What’s New in 2023?” article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA’s Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.
